Authors



Tara Graff, DO

Latest:

Future Directions and Research Priorities in BTKi Treatment Approaches

Panelists discuss how challenges in implementing emerging Bruton tyrosine kinase inhibitor (BTKi) regimens for treatment-naive patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) may include issues related to access, cost, and patient adherence, and highlight the need for ongoing research and collaboration to optimize BTKi use and improve patient outcomes in both diseases.


Jeffrey Dunn, PharmD, MBA

Latest:

Stakeholder Insights on rtCGM in T2D Population Health Management

Leading payer and health system stakeholders reviewed literature and shared insights on the value of real-time continuous glucose monitoring (rtCGM) in type 2 diabetes (T2D) population health.


Abaki Beck, MPH

Latest:

Predictors of and Barriers to Receipt of Advance Premium Tax Credits

Few eligible individuals apply for the Advance Premium Tax Credit due to knowledge barriers. Additionally, specific sociodemographic characteristics appear to predict applying status.


Zeel Shah, MD

Latest:

Medical Home Visit Programs During COVID-19 State of Emergency

This report highlights the unique challenges faced by home health programs in addition to discussing how technology and policy changes have helped the elderly homebound during the coronavirus disease 2019 (COVID-19) pandemic.


Lori Hartwell, CEO, Renal Support Network
Lori Hartwell

Latest:

Contributor: Medicare Policy Proposal Jeopardizes Care for Those on Dialysis

CEOs of 3 kidney care organizations explain flaws in CMS' recent reimbursement proposal.


Aig Unuigbe, PhD

Latest:

High-Need Beneficiary Enrollment Patterns in Medicare Advantage and Traditional Medicare

Accounting for 32% of all Medicare enrollees in 2019, high-need beneficiaries were more likely to be in traditional Medicare than Medicare Advantage.


Sarah K. Dutcher, PhD

Latest:

Preferences for and Experiences With Pill Appearance Changes: National Surveys of Patients and Pharmacists

Changes in generic drug appearance occur often. Patients’ and pharmacists’ responses to those changes vary, with some patients stopping their medication or using it less.


Steven Daniel Daveluy, MD, FAAD

Latest:

Using AI as Augmented Intelligence to Improve Rare Dermatologic Skin Diseases

Steven Daniel Daveluy, MD, FAAD, discussed how artificial intelligence (AI) can leverage extensive patient data and guide dermatologists to improve early diagnosis and treatment of rare dermatological diseases through teledermatology.


Edward C. Norton, PhD

Latest:

Hospital Performance in a Statewide Commercial Insurer Episode-Based Incentive Program

Some hospitals were able to outperform others in a commercial insurer episode-based incentive program, but there was little evidence of global reductions in episode spending.


Lisa Young, MSc

Latest:

Bleeds and Resource Use in Hemophilia B: Retrospective Observational Study

This real-world US study describes individuals with hemophilia B who experience bleeds despite factor replacement therapy and quantifies the associated comorbidity and health care resource utilization burden.


Bruce Dorr, MD, FPMRS, FACOG
Bruce Dorr, MD, FPMRS, FACOG

Latest:

Contributor: In the Misdiagnosis of Menopause, What Needs to Change?

Menopause symptoms are not being recognized, leading to misdiagnosis and improper treatment.


Patrick J. Campbell, PharmD, PhD

Latest:

COPD Treatment Ratio: A Measure for Improving COPD Population Health

This article supports the use of the chronic obstructive pulmonary disease (COPD) treatment ratio as a surrogate marker of COPD exacerbation risk for quality measurement purposes.



Christine E. Chaisson, MPH

Latest:

Teamwork Enhances Patient Experience: Linking TEAM and Net Promoter Scores

In 1386 providers, better teamwork related to higher patient Net Promoter Score (NPS), and the relationship between provider experience and NPS was mediated by teamwork.


Aaron Farberg, MD

Latest:

The VISIBLE Study: Understanding Comorbidities in Psoriasis Across All Skin Tones

An expert discusses how the VISIBLE study examined comorbidity burden in moderate to severe psoriasis across all skin tones, addressing disparities in research. It aimed to highlight unmet needs and improve understanding of disease impact in diverse populations.



Louis D. Falo Jr, MD, PhD

Latest:

Access to Consultative Dermatologic Care via Physician-to-Physician Asynchronous Outpatient Teledermatology

Direct access of primary care physicians to dermatologists via asynchronous teledermatology improves a health system’s ability to increase patient access to dermatologic care.



Toby Maher, MD, PhD

Latest:

Impact of Treatment Delays on Patient Outcomes

Toby Maher, MD, PhD, discusses how delays in treatment for idiopathic pulmonary fibrosis (IPF) can significantly worsen patient outcomes and accelerate disease progression, underscoring the critical need for timely intervention.


Jürgen Unützer, MD, MPH, MA

Latest:

Effective Implementation of Collaborative Care for Depression: What Is Needed?

Factors most important for successful implementation of collaborative care for depression differ for patient activation versus achieving remission; both are critical to program success.


Douglas Eckhardt, MBA

Latest:

A Standardized Care Pathway Increases Optimal Dialysis Starts

The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway.


Alex Sripipatana, PhD, MPH

Latest:

Intersection of Complexity and High Utilization Among Health Center Patients Aged 18 to 64 Years

This paper utilizes latent class analysis to identify subgroups of complex conditions and of super-utilizers among health center patients to inform clinically tailored efforts.


Lin Xie, MS, MA

Latest:

Journey to Anticoagulant Access Following Payer Rejection of Apixaban

Formulary restrictions can create treatment barriers for patients with atrial fibrillation, including unnecessary delays in treatment and prescription abandonment, with vulnerable populations at greater risk.


Nicola Lancki, MPH

Latest:

Costs for Commercially Insured Adults Prescribed Second-line Diabetes Medications

Adults with type 2 diabetes who received nonsulfonylurea medications had relative increases in total costs. Receiving newer medication classes led to relatively decreased medical costs.


Karen Shakiba, BS

Latest:

Increasing Medicare Annual Wellness Visits in Accountable Care Organizations

Through innovations increasing the ease of scheduling and the efficiency of conducting annual wellness visits (AWVs), a large Medicare accountable care organization has been able to increase AWV rates among eligible beneficiaries.


Carrie Nagorka

Latest:

Asthma, Eczema Associated With Higher Risk for Osteoarthritis

The study findings suggest that treatments for allergic reactions could help decrease the risk of having joint problems.


Tao Fan, PhD

Latest:

Outcomes in Patients With IBD Stratified by Risk of Disease Progression

This study validates criteria to identify patients with inflammatory bowel disease (IBD) at risk of worsening disease who may benefit from early treatment with advanced therapies.



Mekhi Washington, BS

Latest:

Addressing STIs Through Managed Care: Opportunities in Medicaid and Beyond

Medicaid and other managed care organizations could take several key steps to respond to the sexually transmitted infection (STI) epidemic in the US, including congenital syphilis.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo